Review of North American pit viper antivenoms
Authors:
Open Access
- 24 January 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 77 (3) , 175-187
Abstract
For the first time in nearly 20 years, 2 antigen-binding fragment (Fab) antivenoms are available to treat patients who incur North American pit viper snakebites: Crotalidae polyvalent immune Fab (ovine), or simply FabAV; and Crotalidae immune F(ab′)2 (equine), or simply F(ab′)2. Pharmacists are in a key position for the selection, dosing, reconstitution, administration, and monitoring of antivenom therapy; however, they encounter inconsistent exposure and experience with these drugs. Thus, an updated review of the literature is necessary. The search strategy and selection incorporated both controlled vocabulary terms and keywords to describe concepts relevant to the search. Retrieval was limited to literature published from 1997 to the present in English, Portuguese, or Spanish. Given the paucity of available prospective literature, the authors elected to include all prospective evidence to best describe the role of antivenom. For the primary literature review, manuscripts were excluded if they were observational studies, conference abstracts, narrative or opinion articles, letters to the editor, or in-progress studies. While there is limited evidence-based guidance on the superiority of F(ab′)2 to FabAV, or vice versa, individual and regional considerations should contribute to formulary decisions. Pharmacists must play a role in the development of clinical pathways to ensure appropriate evaluation, supportive care, and antivenom procurement, administration, and monitoring.Keywords
This publication has 46 references indexed in Scilit:
- Safety and Cost‐Effectiveness of a Clinical Protocol Implemented to Standardize the Use of Crotalidae Polyvalent Immune Fab Antivenom at an Academic Medical CenterPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
- Incidence of Immediate Hypersensitivity Reaction and Serum Sickness Following Administration of Crotalidae Polyvalent Immune Fab Antivenom: A Meta‐analysisAcademic Emergency Medicine, 2012
- Current Management of Copperhead SnakebiteJournal of the American College of Surgeons, 2011
- Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshopBMC Emergency Medicine, 2011
- Snake venom: From fieldwork to the clinicBioEssays, 2011
- Improving Crotalidae polyvalent immune Fab reconstitution timesThe American Journal of Emergency Medicine, 2010
- AAPCC database characterization of native U.S. venomous snake exposures, 2001–2005Clinical Toxicology, 2009
- Copperhead Envenomations In The CarolinasJournal of Toxicology: Clinical Toxicology, 2003
- Envenomations by Rattlesnakes Thought to Be DeadNew England Journal of Medicine, 1999
- The incidence of wound infection following crotalid envenomationThe Journal of Emergency Medicine, 1993